Evaparin Injection contains Enoxaparin 300mg, a low molecular weight heparin used as an anticoagulant to prevent and treat blood clots. It works by inhibiting clotting factors, primarily Factor Xa, thereby reducing the formation of thrombi in veins and arteries. Evaparin is commonly prescribed for the prevention of deep vein thrombosis (DVT) following surgery, including hip or knee replacement, and for the treatment of acute coronary syndromes such as unstable angina and myocardial infarction. It is also used to prevent pulmonary embolism in high-risk patients. Administered via subcutaneous injection, Evaparin offers predictable anticoagulant effects with a lower risk of bleeding complications compared to unfractionated heparin. Patients should follow dosing instructions carefully and inform their healthcare provider of any history of bleeding disorders, recent surgeries, or allergies. Common side effects may include injection site reactions, mild bleeding, or bruising. Serious adverse effects such as severe bleeding or thrombocytopenia require immediate medical attention. Evaparin should be used cautiously in patients with renal impairment or those on concurrent anticoagulant therapy. Regular monitoring of blood parameters may be necessary to ensure safety and efficacy during treatment.